The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
Open accessAbstract
Recent insights into the molecular and cellular mechanisms underlying cancer development have revealed that immune cells functionally regulate epithelial cancer development and progression. Moreover, accumulated clinical and experimental data indicate that the outcome of an immune response toward an evolving breast neoplasm is largely determined by the type of immune response elicited. Acute tumor-directed immune responses involving cytolytic T lymphocytes appear to protect against tumor development, whereas immune responses involving chronic activation of humoral immunity, infiltration by Th2 cells, and protumor-polarized innate inflammatory cells result in the promotion of tumor development and disease progression. Herein we review this body of literature and summarize important new findings revealing the paradoxical role of innate and adaptive leukocytes as regulators of breast carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Self-citationInflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Self-citationA Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer
Veronesi, U., Paganelli, G., Viale, G., Luini, A., Zurrida, S., Galimberti, V., Intra, M., Veronesi, P., Robertson, C., Maisonneuve, P., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa012782 · Cited by 2,210
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Intracellular pattern recognition receptors in the host response
Meylan, E., Tschopp, J., & Karin, M. (2006) · Nature · doi:10.1038/nature04946 · Cited by 1,206
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Romagnani, S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80019-9 · Cited by 1,078
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“This regulation is exemplified by positive correlations between numbers of innate immune cells (macrophages, mast cells and neutrophils) infiltrating human tumors with the number of blood vessels [81,82], and by experimental findings in mouse models where attenuating innate immune cell infiltration of premalignant tis…”
BackgroundSelf-citationRas-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Betts, P., Mokry, B., Risser, D. R., Weiss, N. S., Williams, M. A., Sjoberg, E., Clanton, M. S., Frankel, L. S., Foxhall, L. E., Hancock, L. E., et al. (2004) · Cited by 840
T Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 737
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Self-citationCancer risk after renal transplantation in the nordic countries, 1964–1986
Birkeland, S. A., Storm, H. H., Lamm, L. U., Barlow, L., Blohmé, I., Forsberg, B., Eklund, B., Fjeldborg, O., Friedberg, M., Frödin, L., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600209 · Cited by 613
Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells
Lim, H. W., Hillsamer, P., Banham, A. H., & Kim, C. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4180 · Cited by 600
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Boshoff, C., & Weiss, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc797 · Cited by 443
Humoral immunity, inflammation and cancer
Tan, T.-T., & Coussens, L. M. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.01.001 · Cited by 417
Self-citationCoussens, L. M., & Werb, Z. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.f23 · Cited by 384
Self-citationNK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Disis, M. L., Pupa, S. M., Gralow, J. R., Dittadi, R., Menard, S., & Cheever, M. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.11.3363 · Cited by 345
Derangement of immune responses by myeloid suppressor cells
Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0443-2 · Cited by 335
Stott, D. I., Hiepe, F., Hummel, M., Steinhauser, G., & Berek, C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3234 · Cited by 335
Mantovani, A., Allavena, P., & Sica, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.016 · Cited by 311
Lymphocyte infiltrates as a prognostic variable in female breast cancer
Aaltomaa, S., Lipponen, P., Eskelinen, M., Kosma, V.-M., Marin, S., Alhava, E., & Syrjänen, K. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90134-n · Cited by 286
Tumor vascularity and tryptase‐positive mast cells correlate with a poor prognosis in melanoma
Ribatti, D., Ennas, M. G., Vacca, A., Ferreli, F., Nico, B., Orru, S., & Sirigu, P. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01152.x · Cited by 262
Esposito, I., Menicagli, M., Funel, N., Bergmann, F., Boggi, U., Mosca, F., Bevilacqua, G., & Campani, D. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014498 · Cited by 257
Transgenic Polyoma middle-T mice model premalignant mammary disease.
Maglione, J. E., Moghanaki, D. M., Young, L. J. T., Manner, C. K., Ellies, L. G., Joseph, S. O., Nicholson, B., Cardiff, R. D., & MacLeod, C. L. (2001) · PubMed · Cited by 256
The Inflammatory Tumor Microenvironment and Its Impact on Cancer Development
de Visser, K. E., & Coussens, L. M. (2006) · Contributions to Microbiology · doi:10.1159/000092969 · Cited by 247
Self-citationColombo, M., Dono, M., Gazzola, P., Roncella, S., Valetto, A., Chiorazzi, N., Mancardi, G. L., & Ferrarini, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2782 · Cited by 246
Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation
Stewart, T., Tsai, S.-C., Grayson, H., Henderson, R., & Opelz, G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91618-0 · Cited by 235
Barberá‐Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C., & Sampsel, J. W. (2002) · PubMed · Cited by 233
Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.
Azuma, T., Takahashi, T., Kunisato, A., Kitamura, T., & Hirai, H. (2003) · PubMed · Cited by 224
Trzonkowski, P., Szmit, E., Myśliwska, J., Dobyszuk, A., & Myśliwski, A. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.04.003 · Cited by 223
Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer
Kohrt, H. E., Nouri, N., Nowels, K., Johnson, D., Holmes, S., & Lee, P. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020284 · Cited by 220
Hayakawa, Y., Takeda, K., Yagita∥, H., Smyth, M. J., Kaer, L. V., Okumura, K., & Saiki, I. (2002) · PubMed · Cited by 219
Kim, H.-J., Krenn, V., Steinhauser, G., & Berek, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.3053 · Cited by 218
De novo malignancies after liver transplantation: A major cause of late death
Fung, J. J., Jain, A., Kwak, E. J., Kusne, S., Dvorchik, I., & Eghtesad, B. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.28645 · Cited by 202
Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma
Imada, A., Shijubo, N., Kojima, H., & Abe, S. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.01517.x · Cited by 195
Pellegrini, P., Berghella, A. M., Beato, T. D., Cicia, S., Adorno, D., & Casciani, C. U. (1996) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050244 · Cited by 190
Fc receptors are major mediators of antibody based inflammation in autoimmunity
Hogarth, P. M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00409-0 · Cited by 189
Stout, R. D., & Bottomly, K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.760 · Cited by 184
IL-12 induces T helper 1-directed antitumor response
Tsung, K., Meko, J. B., Peplinski, G. R., Tsung, Y. L., & Norton, J. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3359 · Cited by 184
Penn, I. (1999) · Transplantation Proceedings · doi:10.1016/s0041-1345(98)01987-3 · Cited by 177
Kobayashi, M., Kobayashi, H., Pollard, R. B., & Suzuki, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5869 · Cited by 171
Naturally occurring B-cell responses to breast cancer
Coronella-Wood, J. A., & Hersh, E. M. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0409-4 · Cited by 161
Romagnani, C., Chiesa, M. D., Köhler, S., Moewes, B., Radbruch, A., Moretta, L., Moretta, A., & Thiel, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200526069 · Cited by 158
Hu, H., Urba, W. J., & Fox, B. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3033 · Cited by 153
Cancer Incidence in New York State Acquired Immunodeficiency Syndrome Patients
Gallagher, B. K. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.6.544 · Cited by 151
Where have all the T cells gone? Mechanisms of immune evasion by tumors
Finke, J. H., Ferrone, S., Frey, A. B., Mufson, A., & Ochoa, A. C. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01435-2 · Cited by 150
Ostrand‐Rosenberg, S., Grusby, M. J., & Clements, V. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6015 · Cited by 143
Solid tumors after heart transplantation: Lethality of lung cancer
Pham, S. M., Kormos, R. L., Landreneau, R. J., Kawai, A., González-Cancel, I., Hardesty, R. L., Hattler, B. G. J., & Griffith, B. P. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00120-4 · Cited by 142
Shimokawara, I., Imamura, M., Yamanaka, N., Ishii, Y., & Kikuchi, K. (1982) · Cancer · Cited by 140
Benı́tez-Bribiesca, L., Wong, A., Utrera, D., et al. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900816 · Cited by 131
Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis
Yano, H., Kinuta, M., Tateishi, H., Nakano, Y., Matsui, S., Monden, T., Okamura, J., Sakai, M., & Okamoto, S. (1999) · Gastric Cancer · doi:10.1007/s101200050017 · Cited by 129
McHeyzer‐Williams, M. G. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00046-3 · Cited by 128
Macrophages: Modulators of Breast Cancer Progression
Lin, E. Y., & Pollard, J. W. (2004) · Novartis Foundation symposium · doi:10.1002/0470856734.ch12 · Cited by 127
Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.
Chin, Y., Janseens, J., Vandepitte, J., Vandenbrande, J., Opdebeek, L., & Raus, J. (1992) · PubMed · Cited by 122
T Helper 1 Cytokine mRNA Is Increased in Spontaneously Regressing Primary Melanomas
Lowes, M. A., Bishop, G. A., Crotty, K. A., Barnetson, R. S. C., & Halliday, G. M. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12292705 · Cited by 122
Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis
Fernández-Madrid, F. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.12.017 · Cited by 120
Cabezas, S. C., Serafini, B., Ambrosini, E., Sanchez, M., Penna, G., Adorini, L., & Aloisi, F. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00170-4 · Cited by 110
Cutting Edge: Differentiation of Antitumor CTL In Vivo Requires Host Expression of Stat1
Fallarino, F., & Gajewski, T. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4109 · Cited by 108
Functions of T-cell subsets and cytokines in mycobacterial infections.
Munk, M. E., & Emoto, M. (1995) · PubMed · Cited by 105
Dendritic Cell-Based Immunotherapy
Osada, T., Clay, T. M., Woo, C. Y., Morse, M. A., & Lyerly, H. K. (2006) · International Reviews of Immunology · doi:10.1080/08830180600992456 · Cited by 99
Th1/Th2 cells in inflammatory disease states: therapeutic implications
Moss, R. B., Moll, T., El-Kalay, M., Kohne, C., Hoo, W. S., Encinas, J. A., & Carlo, D. J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.12.1887 · Cited by 99
Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.
Coronella, J. A., Telleman, P., Kingsbury, G. A., Truong, T., Hays, S. R., & Junghans, R. P. (2001) · PubMed · Cited by 88
Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice
Kacha, A. K., Fallarino, F., Markiewicz, M. A., & Gajewski, T. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6024 · Cited by 83
Angiogenesis and inflammation in ductal carcinoma in situ of the breast
Lee, A. H. S., Happerfield, L. C., Bobrow, L. G., & Millis, R. R. (1997) · The Journal of Pathology · Cited by 81
Rudolf Virchow and Modern Aspects of Tumor Pathology
David, H. (1988) · Pathology - Research and Practice · doi:10.1016/s0344-0338(88)80138-9 · Cited by 78
Barberá‐Guillem, E., May, K. F., Nyhus, J. K., & Nelson, M. B. (1999) · Neoplasia · doi:10.1038/sj.neo.7900054 · Cited by 73
Chen, W. (2006) · Frontiers in bioscience · doi:10.2741/1889 · Cited by 67
Functional Analysis of Tumor-Infiltrating Leukocytes in Breast Cancer Patients
Wong, P. Y., Staren, E. D., Tereshkova, N., et al. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5301 · Cited by 64
Links between innate and cognate tumor immunity
Ghiringhelli, F., Apétoh, L., Housseau, F., Kroemer, G., & Zitvogel, L. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.02.003 · Cited by 61
Siegel, C., Schreiber, K., Meredith, S. C., Beck‐Engeser, G., Lancki, D. W., Lazarski, C. A., Fu, Y., Rowley, D. A., & Schreiber, H. W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1945 · Cited by 58
Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes
Punt, C. J. A., Barbuto, J. A. M., Zhang, H., et al. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01533513 · Cited by 53
Whitford, P., George, W. D., & Campbell, A. M. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90174-t · Cited by 45
Immunological enhancement of primary tumor development and its prevention
Schreiber, H. W., Wu, T. H., Nachman, J. B., & Rowley, D. A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0331 · Cited by 36
Jaume, J. C., Portolano, S., Prummel, M. F., McLachlan, S. M., & Rapoport, B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106623 · Cited by 33
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer
Tan, E. M., & SHI, F.-D. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02259.x · Cited by 32
Immune cells as anti‐cancer therapeutic targets and tools
Johansson, M., Tan, T., de Visser, K. E., & Coussens, L. M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21230 · Cited by 26
Self-citationPistoia, V., & Corcione, A. (1995) · Stem Cells · doi:10.1002/stem.5530130506 · Cited by 24
B-cell: a logical target for treatment of rheumatoid arthritis.
Youinou, P., Jamin, C., & Saraux, A. (2007) · PubMed · Cited by 16
Leibowitch, M., Droz, D., No�l, L.-H., Avril, M.-F., & Leibowitch, J. (1981) · Journal of Clinical Immunology · doi:10.1007/bf00915389 · Cited by 15
Jj, E. (1981) · PubMed · Cited by 15
Sentinel-Node Biopsy in Breast Cancer
Badwe, R. A., Thorat, M. A., & Parmar, V. V. (2003) · New England Journal of Medicine · doi:10.1056/nejm200311133492017 · Cited by 12
Cited by
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
DeNardo, D. G., Barreto, J. B., Andreu, P., Vasquez, L., Tawfik, D., Kolhatkar, N., & Coussens, L. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.018 · Cited by 1,353
Self-citationKathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Savas, P., Virassamy, B., Ye, C., Salim, A., Mintoff, C. P., Caramia, F., Salgado, R., Byrne, D. J., Teo, Z. L., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0078-7 · Cited by 992
Breast Cancer Immunotherapy: Facts and Hopes
Emens, L. A. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3001 · Cited by 863
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Metadata
- Authors
- DeNardo, D. G., & Coussens, L. M.
- Venue
- Breast Cancer Research
- Published
- 2007-08
- Volume
- 9
- Issue
- 4
- Pages
- 212-212
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2031576122
- Cited by
- 677
- References
- 104
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.